NephrosNEPH
About: Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.
Employees: 31
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
0.39% less ownership
Funds ownership: 41.04% [Q2] → 40.65% (-0.39%) [Q3]
6% less funds holding
Funds holding: 18 [Q2] → 17 (-1) [Q3]
20% less capital invested
Capital invested by funds: $9.17M [Q2] → $7.33M (-$1.84M) [Q3]
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
100% less funds holding in top 10
Funds holding in top 10: 1 [Q2] → 0 (-1) [Q3]
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
Benchmark Robert Wasserman 42% 1-year accuracy 16 / 38 met price target | 225%upside $5 | Speculative Buy Reiterated | 12 Nov 2024 |
